Ginseng saponins and the treatment of osteoporosis: mini literature review
Open Access
- 15 July 2013
- journal article
- review article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 37 (3), 261-268
- https://doi.org/10.5142/jgr.2013.37.261
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-FosBone, 2012
- Ginseng and Diabetes: The Evidences from In Vitro, Animal and Human StudiesJournal of Ginseng Research, 2012
- Ginsenoside Rh2(S) induces differentiation and mineralization of MC3T3-E1 cells through activation of the PKD/AMPK signaling pathwaysInternational Journal of Molecular Medicine, 2011
- A Review on Current Osteoporosis Research: With Special Focus on Disuse Bone LossJournal of Osteoporosis, 2011
- Retinoblastoma binding protein-1 (RBP1) is a Runx2 coactivator and promotes osteoblastic differentiationBMC Musculoskeletal Disorders, 2010
- Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyteBiochemical and Biophysical Research Communications, 2007
- Biology of RANK, RANKL, and osteoprotegerinArthritis Research & Therapy, 2007
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- Osteoclast differentiation and activationNature, 2003
- Intracellular signalling: The Mad way to do itCurrent Biology, 1996